Perioperative Management of Type 2N Von Willebrand’s Disease with Recombinant Factor VIII in a Patient Undergoing Knee-Replacement Surgery
Joint Authors
Dukka, Srivasavi
Allsup, David John
Source
Issue
Vol. 2013, Issue 2013 (31 Dec. 2013), pp.1-2, 2 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2013-02-03
Country of Publication
Egypt
No. of Pages
2
Main Subjects
Abstract EN
Type 2N Von Willebrand's disease (2N VWD) is a rare, recessively inherited bleeding disorder, comprising 1-2% of all VWD patients, usually manifesting as a mild bleeding diathesis.
Treatment includes desmopressin (DDAVP) or intermediate purity plasma-derived FVIII concentrates containing residual VWF.
We present a case of a 75-year-old gentleman, incidentally diagnosed with type 2N VWD in 2002 on routine blood testing before surgery with an ISTH bleeding score of 1-2, who was treated with recombinant FVIII preoperatively.
American Psychological Association (APA)
Dukka, Srivasavi& Allsup, David John. 2013. Perioperative Management of Type 2N Von Willebrand’s Disease with Recombinant Factor VIII in a Patient Undergoing Knee-Replacement Surgery. Case Reports in Hematology،Vol. 2013, no. 2013, pp.1-2.
https://search.emarefa.net/detail/BIM-502165
Modern Language Association (MLA)
Dukka, Srivasavi& Allsup, David John. Perioperative Management of Type 2N Von Willebrand’s Disease with Recombinant Factor VIII in a Patient Undergoing Knee-Replacement Surgery. Case Reports in Hematology No. 2013 (2013), pp.1-2.
https://search.emarefa.net/detail/BIM-502165
American Medical Association (AMA)
Dukka, Srivasavi& Allsup, David John. Perioperative Management of Type 2N Von Willebrand’s Disease with Recombinant Factor VIII in a Patient Undergoing Knee-Replacement Surgery. Case Reports in Hematology. 2013. Vol. 2013, no. 2013, pp.1-2.
https://search.emarefa.net/detail/BIM-502165
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-502165